BP
INCY icon

Ballentine Partners’s Incyte INCY Stock Holding History

Ballentine Partners’s Portfolio INCY Stock Details INCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$546K Sell
4,816
-35
-0.7% -$3.47K 0.01% 541
2026
Q1 		$457K Sell
4,851
-67
-1% -$6.68K 0.01% 560
2025
Q4 		$486K Buy
4,918
+82
+2% +$7.93K 0.01% 516
2025
Q3 		$410K Buy
4,836
+12
+0.2% +$949 0.01% 576
2025
Q2 		$329K Buy
4,824
+138
+3% +$8.74K ﹤0.01% 654
2025
Q1 		$284K Sell
4,686
-649
-12% -$45.3K ﹤0.01% 649
2024
Q4 		$368K Buy
5,335
+666
+14% +$47.5K 0.01% 518
2024
Q3 		$309K Sell
4,669
-58
-1% -$3.7K 0.01% 573
2024
Q2 		$287K Buy
4,727
+182
+4% +$10.3K 0.01% 577
2024
Q1 		$259K Buy
4,545
+83
+2% +$4.98K ﹤0.01% 591
2023
Q4 		$280K Buy
+4,462
New +$252K 0.01% 521
2023
Q1 		– Sell
-2,609
Closed -$210K – 582
2022
Q4 		$210K Buy
+2,609
New +$200K 0.01% 451
2017
Q3 		– Sell
-1,739
Closed -$232K – 452
2017
Q2 		$232K Buy
+1,739
New +$221K 0.02% 320

Other funds holding INCY

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ballentine Partners's INCY Position: Q2 2026 in Review

Ballentine Partners reduced its Incyte (INCY) stake by 0.72% in Q2 2026, selling an estimated $3.47K and leaving 4,816 shares worth $546K. The position accounts for 0.01% of the portfolio, ranked #541.

Ballentine Partners first reported a position in INCY in Q2 2017 and has held it in 13 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Ballentine Partners held 4,816 shares of Incyte worth $546K as of Q2 2026.
  • Ballentine Partners sold 35 Incyte shares in Q2 2026, an estimated $3.47K.
  • Incyte made up 0.01% of Ballentine Partners's portfolio in Q2 2026, its #541 holding.
  • Ballentine Partners first reported a position in Incyte in Q2 2017 and has held it in 13 quarters since.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.